GlassScriptPhysician profile
Bakht Roshan
NPI 1639201502
$2,737.12
in general payments reported to CMS, 2019-2025
20 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $437 · 2021: $328 · 2022: $489 · 2023: $21.12 · 2024: $593 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766 · Education: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.19 |
| Education | $255.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $506.17 | 2019-2024 | |
| Abbvie INC. | $454.01 | 2022-2025 | Mavyret |
| Astellas Pharma US INC | $301.73 | 2024-2025 | Cresemba |
| Mayne Pharma Commercial LLC | $225.75 | 2020-2022 | |
| Janssen Products, LP | $198.00 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $188.68 | 2019-2025 | Zerbaxa |
| Viiv Healthcare Company | $159.33 | 2019-2025 | Cabenuva, Apretude, Dovato |
| Hologic Sales and Service, LLC | $139.45 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $100.00 | 2019 | |
| Janssen Biotech, INC. | $80.73 | 2019-2021 | |
| Philips North America LLC | $66.92 | 2019-2022 | |
| United Therapeutics Corporation | $56.20 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $51.65 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.81 | 2021-2022 | |
| Genzyme Corporation | $38.49 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $33.67 | 2025 | Brinsupri, Arikayce |
| Allergan, INC. | $33.00 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $24.89 | 2021 | |
| Fisher & Paykel Healthcare INC | $18.37 | 2022 | |
| Kci USA, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bakht Roshan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.